Burundi

Reimbursed Care Access

Burundi is a party to international drug‑control treaties that limit psychotropic and narcotic substances to medical and scientific uses; its national penal code contains provisions criminalizing illicit production, possession and supply of controlled substances. Ketamine is recognized internationally as an essential injectable anaesthetic (WHO) and is therefore used in routine medical care in many low‑resource settings, but there is no publicly available evidence of a national reimbursement or formal regulatory framework in Burundi that authorises psychedelic-assisted indications (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, mescaline, 2C‑X) outside approved clinical research. [https://treaties.un.org/Pages/ViewDetails.aspx?chapter=6&mtdsg_no=VI-16&lang=en&mtdsg_no=VI-16|UN Treaty Collection (1971 Convention)] [https://insp.gov.bi/|Institut National de Santé Publique du Burundi] [https://medlistapp.paho.org/en/list/11|WHO Model List of Essential Medicines: ketamine]